Tesamorlin

Tesamorelin is a synthetic analog representing the first 29 amino acids of human growth hormone-releasing hormone (GHRH), engineered with a trans-3-hexenoic acid group at the N-terminal tyrosine residue to optimize stability, biological activity, and pharmacokinetic performance compared to native GHRH.

• Endogenous Growth Hormone Stimulation: Binds directly to GHRH receptors to stimulate the pulsatile synthesis and secretion of endogenous growth hormone (GH).

• Targeted Visceral Adiposity Clearance: Promotes lipolysis with a specific affinity for reducing deep visceral adipose tissue (VAT) accumulation.

• Optimized Metabolic Stability: The N-terminal modification significantly extends enzymatic half-life, allowing for sustained receptor engagement and reliable research modeling.

Disclaimer: This product is sold strictly for laboratory research purposes only. Not for human or veterinary consumption, clinical trials, or therapeutic use.